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Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that affects
cognition and memory. Recent advances have helped identify many clinical sub-types
in AD. Mounting evidence point toward structural polymorphism among fibrillar aggregates of amyloid-β (Aβ) to being responsible for the phenotypes and clinical manifestations. In the emerging paradigm of polymorphism and prion-like propagation of
aggregates in AD, the role of low molecular weight soluble oligomers, which are long
known to be the primary toxic agents, in effecting phenotypes remains inconspicuous. In this study, we present the characterization of three soluble oligomers of Aβ42,
namely 14LPOs, 16LPOs, and GM1Os with discreet biophysical and biochemical
properties generated using lysophosphatidyl glycerols and GM1 gangliosides. The
results indicate that the oligomers share some biophysical similarities but display
distinctive differences with GM1Os. Unlike the other two, GM1Os were observed
to be complexed with the lipid upon isolation. It also differs mainly in detection by
conformation-sensitive dyes and conformation-specific antibodies, temperature and
enzymatic stability, and in the ability to propagate morphologically-distinct fibrils.
GM1Os also show distinguishable biochemical behavior with pronounced neuronal
toxicity. Furthermore, all the oligomers induce cerebral amyloid angiopathy (CAA)
and plaque burden in transgenic AD mice, which seems to be a consistent feature
among all lipid-derived oligomers, but 16LPOs and GM1Os displayed significantly
higher effect than the others. These results establish a correlation between molecular
features of Aβ42 oligomers and their distinguishable effects in transgenic AD mice
attuned by lipid characteristics, and therefore help bridge the knowledge gap in understanding how oligomer conformers could elicit AD phenotypes.

Abbreviations: 14LPOs, C14 lysophospholipid-derived oligomers; 16LPOs, C16 lysophospholipid-derived oligomers; Aβ, Amyloid-β; CAA, cerebral
amyloid angiopathy; CMC, critical micelle concentration; GM1Os, GM1 ganglioside-derived oligomers; LFAOs, large fatty acid-derived oligomers; LMW,
low molecular weight; ThT, thioflavin-T.
Jhinuk Saha and Dexter N. Dean contributed equally to this study.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited and is not used for commercial purposes.
© 2021 Federation of American Societies for Experimental Biology
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IN TRO D U C T ION

Alzheimer disease (AD) is a fatal neurodegenerative disorder
characterized by a progressive and irreversible cognitive decline and memory loss among the elderly. The AD brain is characterized by two pathological hallmarks; intracellular tangles
comprised of hyper-phosphorylated tau protein and extracellular plaques composed of amyloid-β (Aβ) peptide aggregates.1
However, the levels of low molecular weight (LMW) oligomers
of Aβ correlate better with cognitive decline.2-5 It has now been
well established that LMW oligomers are the primary toxic
species responsible for early neuronal dysfunction in AD.6-8
Therefore, understanding how Aβ oligomers are generated and
what their structural features are, is of significant interest that
may hold the key to the development of therapeutics for AD.
The stochasticity involved in Aβ aggregation, especially
during early stages, gives rise to multiple pathways of aggregation and with a diverse range of aggregate sizes and conformations.9 Because of this, conformational heterogeneity and
structural polymorphism are commonly observed among Aβ
aggregates.10-14 Perhaps a profound impact of this is that the
aggregate polymorphism may direct correlate to the clinical
phenotypes observed among AD patients.15-18 Aggregates
with distinct conformations have been identified among both
familial and idiopathic AD brains.18 Differences in the structure between Aβ fibrils propagated with endogenous seed derived from rapid-onset (rAD) and sporadic AD brains have
reinforced the idea that conformational strains are in part responsible for different phenotypes observed.19 Therefore, understanding the relationship between aggregate conformation
and their pathological function, along with the mechanisms
underlying strain generation and propagation, has become
imperative in deciphering AD pathogenesis.
Aβ aggregation is sensitive to the environmental conditions
and interactions with other biomolecules.20-22 Being a part of
the transmembrane domain of the amyloid precursor protein
(APP), Aβ is influenced by membrane lipids during the early
stages of Aβ aggregation.23-27 Lipid-associated Aβ has also
been observed among AD patients. For instance, a novel membrane-bound Aβ species was isolated from postmortem AD
brains that were thought to trigger early stages of disease pathology.28,29 Aβ was also observed to be tightly bound to GM1
gangliosides, one of the most abundant gangliosides in the brain
and constitutes a prime component of lipid rafts.30 It was later
determined that GM1 binds Aβ with micromolar (μM) affinity31,32 and induces a β-sheet secondary structure transition.33-36

Aβ also binds and undergoes a structural transition to β-sheet
in the presence of negatively charged lipid bilayer vesicles
(liposomes).37-39 Similarly, micelles made up of spherical
monolayers have also been shown to stimulate Aβ aggregate
formation.40,41 Work from our lab has shown that distinct oligomers of Aβ are generated in the presence of anionic micelles
composed of fatty acids. These oligomers, termed large-fatty
acid-derived oligomers (LFAOs) show many interesting biophysical and biochemical properties.9,22,42-45 LFAOs undergo
faithful propagation to fibrils containing repeating oligomer
assemblies in vitro,9 and a bilateral injection of these oligomers
into neonatal CRND8 transgenic AD mice selectively induced
Aβ deposition within the cerebral vasculature, leading to a condition known as cerebral amyloid angiopathy (CAA).45 This led
us to hypothesize that the faithful propagation of biophysically
distinguishable Aβ oligomers toward structurally distinct fibrils
may underpin the mechanisms governing clinical manifestations in AD. In this report, we sought to investigate the effect of
micelle-forming anionic phospholipids on the biophyscial and
biochemical characteristics of oligomers specifically using two
anionic lysophosphatidyl glycerols (LPGs) with varying acyl
chain lengths and a neutral sphingolipid, GM1 ganglioside.
LPGs are good models of micellar phospholipids, while GM1
gangliosides are a major component of membrane lipids and
lipid rafts. We show that the LPG-derived oligomers, 14LPOs
and 16LPOs, share many biophysical properties with LFAOs,
while GM1-derived oligomers, GM1Os show some commonality but are more biophysically distinctive than the other
oligomers. They also induce higher degrees of cytotoxicity and
exacerbation of amyloid pathology in CRND8 mice brains.
In addition, GM1Os and 16LPOs also induce highest level of
CAA phenotype among the oligomers. These results bring to
light how the physiochemical nature of micellar lipids can be
tuned to induce biophysically distinguishable oligomers and
how such properties correlate with their effect in mice brains.
These results also refocus our attention toward unifying and differential characteristics of lipid-derived oligomers to potentiate
as “strains” in inducing specific phenotypes in AD.
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Materials

Lyophilized stocks of synthetic Aβ42 WT were purchased from the Yale School of Medicine (New Haven,
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CT) and from Dr Chakraborty's lab at the University of
Mississippi. The monoclonal antibody Ab5 was obtained
from Levites lab at the University of Florida (Gainesville,
FL). Size exclusion chromatography (SEC) columns
(Superdex-75 HR 10/30) were purchased from GE Life
Sciences (Marlborough, MA). LPG (C14:0 and C16:0)
and GM1 lipids were purchased from Avanti Polar Lipids,
Inc (Alabaster, AL) while C12:0 NEFA was purchased
from NuCheck Prep, Inc (Elysian, MN). Tris base, Tris
hydrochloride, and sodium dodecyl sulfate (SDS) were
purchased from Sigma-Aldrich (St. Louis, MO). Other
routinely used chemicals, reagents, and consumables were
purchased from either VWR, Inc (Radnor, PA) or Thermo
Fisher Scientific, Inc (Waltham, MA).

2.2

|

Purification of Aβ monomers

Synthetic Aβ (0.5-2 mg of lyophilized peptide) was dissolved in 490 μL of nanopure H2O (npH2O) and allowed to
stand at 25°C for 0.5-1 hours. Ten minutes before loading
onto a Superdex-75 HR 10/30 SEC column attached either to
an AKTA FPLC system (GE Healthcare, Buckinghamshire)
or a BioLogic DuoFlowTM system (Bio-Rad), NaOH was
added to a final concentration of 10 mM. Monomer was
then purified by loading the sample onto a pre-equilibrated
(20 mM Tris, pH 8.0) column and fractionating at a flow
rate of 0.5 mL/min at 25°C. Fractions of 500 μL were collected, and monomeric Aβ was found to elute in between
23 and 27 fractions. Cary 50 UV–vis spectrometer (Agilent
Technologies, Inc; Santa Clara, CA) was used to determine
the molar concentration of Aβ in each fraction using BeerLambert's law (ε = 1450 cm−1 M−1 at 276 nm corresponding to the single tyrosine residue). Matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry
(MALDI-Tof) was used to confirm the purity and integrity
of the peptide. The purified monomers were stored at 4°C
in siliconized Eppendorf tubes to minimize protein retention on the tubes and used to initiate experiments within
48 hours of purification.

2.3

|

Purification of Aβ oligomers

Purification of Aβ oligomers was initiated by incubating
freshly purified Aβ monomer (50 μM) with the specified lipid species in the conditions listed below. LFAOs,
5 mM C12:0 NEFA; 14LPO, 0.4 mM C14:0 LPG; 16 LPO,
0.15 mM C16:0 LPG; GM1O, 75 μM GM1. Additionally,
50 mM NaCl and 0.01% NaN3 were added to all reactions prior to incubation at 37°C in quiescent conditions
for 48 hours. The samples were then purified via SEC, as
described above, after first pelleting the insoluble peptide

|
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by centrifugation at 18 000g for 20 minutes. Fractions of
500 μL were collected, and Aβ oligomers were fractionated in the 18-20 fractions. The molar concentration was
determined by UV–vis spectroscopy, as described above.
Samples were either stored at 4°C in siliconized Eppendorf
tubes and used for experimentation within 72 hours or lyophilized and kept at −80°C for extended storage prior to
experimentation.

2.4

|

Lyophilization and resuspension of Aβ

For lyophilization, aliquots of either 1 or 5 μg were made
and flash-frozen by plunging into liquid N2 for 30 seconds
prior to freeze-drying overnight using a FreeZone TriadTM
freeze dry system (Labconco Corp.; Kansas City, MO) maintained at 0.420 mBar. Lyophilized samples were then stored
at −80°C until use. To resuspend the lyophilized samples
for experimentation, either nanopure H2O or Tris buffer (pH
8.0) was added to reach the desired molar concentration of
peptide, and the sample was allowed to stand at 4°C for at
least 1 hour prior to centrifugation at 18 000 g for 20 minutes. The supernatant was then carefully removed and used
for experiments.

2.5

|

Generation of Aβ fibrils

Aβ monomer (100-150 μM) was added to 150 mM NaCl
and allowed to incubate at 37°C in quiescent conditions for
4-5 days for Fon generation. After incubation, the sample
was subjected to centrifugation at 18 000 g for 20 minutes
before carefully discarding the supernatant and resuspending
the pellet in fresh 20 mM Tris (pH 8.0) with 0.01% NaN3.
ThT fluorescence and centrifugation were used to determine
percentage conversion to Aβ fibrils, which was typically
80%-90%. Fibrils were stored at 4°C and used within 30 days.

2.6

|

Oligomer seeding reactions

Aβ monomer (25 μM) was seeded with 5 μM oligomer seeds
in 20 mM Tris (pH 8.0) with 50 mM NaCl and 50 μM ThT.
The reactions were kept in BioTek Synergy 96 well plate
reader at 37°C and ThT fluorescence was monitored up to
48 hours. All experiments were carried out by adding 200 µL
of the reaction mixture in Corning 96-well plate (black). ThT
fluorescence was recorded after an interval of every 10 minutes using excitation at 452 nm and emission at 485 nm at
37°C, shaking samples for 1 second before each read. The
kinetics data were processed by subtracting the blank buffer
reading from the experimental data followed by normalization using the OriginLab 8.0 program.

4 of 18
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2.7 | Partially denaturing and PAGE with
immunoblotting

2.9 | Fourier transform infrared (FTIR)
spectroscopy

Samples were diluted into 1× Laemmli loading buffer with
1% SDS and loaded without boiling, onto either 4%-12%
NuPAGE or 4%-20% Bis-Tris Bio-Rad TGX gels. Prestained molecular-weight markers (Novex Sharp Protein
Standard, Life Technologies) were run in parallel for MW
determination in denaturing PAGE. For immunoblotting,
proteins were transferred onto a 0.2 μm nitrocellulose
membrane (Bio-Rad). Following the transfer, the immunoblot was boiled for 1 minutes in a microwave oven in
1× PBS, followed by blocking for 1.5 hours at 25°C in 1×
PBS containing 5% nonfat dry milk with 1% Tween 20.
Blots were then probed overnight at 4°C with a 1:6000 dilution of Ab5 monoclonal antibody, whose epitope is 1-16
sequence of Aβ. Following primary incubation, blots were
probed with a 1:6000 dilution of anti-mouse, horseradish
peroxidase-conjugated secondary antibody for 1.5 hours at
25°C before being imaged using a Super SignalTM West
Pico Chemiluminescent Substrate kit (Thermo Fisher
Scientific). Dot blots. Samples (225 ng in 5 µL) were spotted onto a 0.2 µm nitrocellulose membrane and allowed to
dry at room temperature for 1 hour. The blots were blocked
for 1.5 hours with 1× PBS containing 5% nonfat dry milk
and probed overnight at 4°C with 1∶2000 and 1:6000 dilutions of polyclonal conformational specific antibody OC
(Millipore Inc) and A11, respectively, along with Ab5 monoclonal antibody. Blots were then incubated with anti-rabbit
(for OC and A11) or anti-mouse (for OC) horseradish peroxide (HRP) conjugated secondary antibody for 1.5 hours
and developed with ECL reagent (Thermo Scientific).

Lyophilized Aβ samples were resuspended in D2O to a final
concentration of 1 mM before accumulating spectra on a
Nicolet 6700 instrument equipped with an ATR accessory. A
total of 64 accumulations were collected by scanning 4000650 cm−1 at a resolution of 4 cm−1. Spectra were processed
by blank subtraction (using D2O as the blank) and baseline
correction using the OriginLab 8.0 program.

2.8
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Curcumin and ANS fluorescence

Curcumin, and 8-anilino-napthalene-1-sulfonic acid
(ANS) fluorescence were measured on a Cary Eclipse
AQ6fluorometer (Agilent Technologies, Inc) in scan mode.
Fluorescence spectra for curcumin were obtained by exciting the sample at 430 nm, while scanning emission between
470 and 600 nm upon the addition of buffered Aβ samples
(5-7 μM) and curcumin (5 μM) in 25% EtOH. The slit widths
for excitation and emission were kept constant at 10 nm.
The data were normalized against the concentrations of the
oligomers and averaged for three independent data sets. For
ANS, Aβ samples (3 μM) were equilibrated for 2 minutes
with ANS (100 μM) in 20 mM Tris pH 8.00 before measuring the fluorescence using excitation at 388 nm and scanning
emission between 400 and 650 nm. The integrated intensity
was plotted against the wavelength for each sample was plotted as bar-graphs and averaged for three independent data
sets.

2.10 | Circular dichroism (CD)
spectroscopy and thermal denaturation
Far UV CD spectra (260-190 nm) for the oligomers (5-8 µM)
were collected on a Jasco (Easton, MD) J-815 spectropolarimeter using a 1 mm pathlength cuvette with an average
of 6-16 spectral scans at a rate of 50 nm/min (8 seconds response time, 1 nm bandwidth, 0.1 nm data pitch). Averaged
spectra were smoothed using the Savitzky-Golay algorithm
with a convolution width of 15 using the Jasco spectrum
analysis program. Temperature stability analysis was performed using SDS as a denaturant as described prior.46
Briefly, SDS (1% wt/vol) was added to a solution of Aβ
oligomers (1 μM) in a 1 cm pathlength cuvette, followed
by heating from 10 to 90°C, while monitoring the signal at
208 nm that corresponds to the emergence of an α-helical
structure. In addition, the far-UV scans of pre- and postmelt samples were measured. The data were processed by
normalizing from 0 to 1, where 1 and 0 represent the fully
melted and unmelted oligomers, respectively. The normalized values of fully melted samples were calculated by correlating the 90°C data with the post-melt scans wherein the
maximum difference in ellipticity between 222 and 208 nm
to be <0.1 was considered to be 100% helix based on established observations on SDS-protein systems.47-49 The data
obtained was fit using the Boltzman function in OriginLab
8.0 program to derive Tm values.
Thermodynamic deconvolution of the data was performed
as follows: The equilibrium constant K at a given temperature
is expressed as:

K=

[N]
[D]

where N and D represent native and denatured oligomers,
respectively. The change in.
The fraction denatured, α is expressed as:

𝛼=

[𝜃] − [𝜃]N
[D]
=
[D] + [N] [𝜃]D − [𝜃]N
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where θ is the ellipticity at λ208 and K is expressed as,

K=

𝛼
1−𝛼

As we know,

ΔG = −RT ln K = ΔH − TΔS
From this, we can deduce,

ln

(

𝛼
1−𝛼

)

=−

ΔH ΔS
+
RT
R

From this equation, linear vant Hoff's plots were generated from which ΔH and ΔS were calculated from the slope
and y-intercept, respectively.

2.11

|

Dynamic light scattering (DLS)

DLS was collected by averaging 12 runs of 10 seconds each
with a pre-equilibration time of 30 seconds using a Zetasizer
Nano S instrument (Malvern, Inc, Worcestershire, UK) with
70 µL volume and 1 cm cuvette pathlength. The diameter was
determined using the volume (%) function.

2.12 | Electrospray ionization mass
spectrometry (ESI-MS)
All samples were evaporated to dryness using vacuum evaporation followed by resuspension at a concentration of 10 μM
in a H2O:CH3CN:HCOOH (1:1:0.2) solvent. Samples were
analyzed by direct infusion into a FinniganTM LXQTM ion
trap mass spectrometer (Thermo Fisher Scientific) operated
in negative ion mode. Signals were accumulated by scanning the spectrum from 150 to 2000 m/z for a total of 3 minutes (~800 total scans) at a constant flow rate of 100 μL/
min. Other instrument parameters were kept as follows: spray
voltage (5 kV), capillary temperature (275°C), capillary voltage (−42 V), and automatic gain control (1.5 × 104).

2.13

|

Analytical ultracentrifugation

Sample Preparation A 4 mM stock solution of HiLyte 647
in 50% DMSO was diluted to 160 μM aliquot, which was
incubated with 10 μM isolated oligomer (14LPO, 16LPO,
LFAO & GM1O) in 10 mM sodium phosphate buffer at pH
8, and was incubated overnight at 4°C kept with constant
orbital shaking at 80 rpm. The free dye was removed from
the dye-protein mixture using 7 kDa Zeba Spin desalting

|
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columns in 10 mM sodium phosphate buffer at pH 8 (Thermo
Scientific) by centrifuging samples at 900 g at 4°C for 1 minutes. The dye and protein absorbance were measured using
a Cary 50 UV–vis spectrometer (Agilent Technologies, Inc;
Santa Clara, CA) to determine the amount of dye bound
to protein. Sedimentation velocity experiments were performed in a Beckman XL-I centrifuge (Beckman Coulter,
Inc, Indianapolis, IN) using absorbance and interference optics by measuring intensity scans at 280 nm at the Physical
Biochemistry Facility at Florida State University. The experiments were performed at 20°C in two-channel Epon centerpieces with an AN60 Ti rotor at 55, 000 rpm. A 10 mM
sodium phosphate at pH 8.0 buffer was the used for protein
solubilization. Data were processed and analyzed using the
SedFit program50 to generate c(S) and MW distributions. The
frictional coefficient (f/f0) value of 1.4 was used for data processing and calculations. The partial specific volume at 20°C
of the protein (0.7021 cm3 g−1) was used that was estimated
from the peptide sequence.

2.14

|

Proteinase K (PK) digestion

A 20 mg/mL of PK stock solution from Ambion was diluted
to 57 ng/mL in 20 mM Tris pH 8.0 to digest 451.5 ng of
each oligomer sample (16LPO, 14LPO, GM1O, and LFAO)
by shaking at 200 rpm at 37°C for 40, 30, 20, and 10 minutes, respectively. The reactions were quenched with 0.5 mM
PMSF for 1 minute. Subsequently, ~337 ng of protein for
each oligomer sample was run on 1% SDS PAGE gel and
we transferred onto a 0.2 μm nitrocellulose membrane (BioRad) for immunoblotting. Immunoblots were probed with a
1:6000 dilution of Ab5 monoclonal antibody & anti-mouse,
horseradish peroxidase-conjugated secondary antibody, respectively. The immunoblots were imaged using a Super
Signal West Pico Chemiluminescent Substrate kit (Thermo
Fisher Scientific). Oligomer band intensities in the gel were
calculated by choosing a 6 mm2 area between molecular
weight 50-80 kDa and subtracting the intensity of blank on
a similar area of the gel with the help of Image Lab (BioRad) software. Intensity vs time plots were then plotted using
OriginLab 8.0.

2.15

|

Atomic force microscopy

Peptide oligomer and fibril samples were prepared following
our previously published procedure.46 An acidic solution of
3-aminopropyltriethoxysilane (500 µL of APTES in 50 mL of
1 mM acetic acid) was prepared and 150 µL was deposited
onto freshly cleaved mica. After 20 minutes, the solution was
decanted from the surface and the substrate was washed three
times with 150 µL of nanopure DI H2O. The substrates were

6 of 18
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then dried with a stream of N2 and set in a desiccator for an
hour. AFM samples were then prepared by depositing 150 µL
of oligomer or fibril solution (2 µM in 20 mM Tris-HCl, pH
8.0). After 30 minutes, the solution was decanted and the substrates were dried under a stream of N2. AFM samples were
stored in the desiccator until imaging. Image analysis was
conducted using a Dimension Icon Atomic Force Microscope
(Bruker) in PeakForce Tapping mode equipped with an
SNL-C cantilever (nom. tip radius of 2 nm; nom. resonance
frequency of 56 kHz; nom. spring constant of 0.24 N/m) in a
standard probe holder under ambient conditions. Images were
acquired with 512 × 512 data point resolution in NanoScope
v8.15 software and analyzed in NanoScope Analysis v1.50.

2.16

|

NMR

The 1H NMR spectra were acquired on the Bruker Advance—
III-HD 850 MHz NMR spectrometer equipped with a Bruker
TCI cryoprobe at the high field NMR facility of the University
of Alabama, Birmingham. The spectra of the samples (1012 μM) in 10 mM phosphate buffer at pH 8.0 with 10% D2O
were collected at 25°C with 6144 or 8192 scans with 14 ppm
sweep width centered around water peak with a D1 delay of
1.0 second. Excitation-sculpting water suppression (zgesgp)
was used. The data were processed using Bruker TopSpin 3.5
analysis software with standard methods with phase corrections.

2.17

|

Cell viability XTT assay

SH-SY5Y human neuroblastoma cells (ATCC, Manassas,
VA) were plated in a clear 96 well-plate at a density of approximately 20 000 cells/well in growth media containing
1:1 mixture of DMEM/F12 medium with 10% fetal bovine
serum and 1% Pen-Strep at 37°C in a humidified atmosphere of 5.5% CO2. After 24 hours, media was replaced
with freshly prepared Aβ oligomers in siliconized tubes resuspended in growth media and incubated for 40 hours. Cell
viability assay was performed using 2,3-bis(2-methoxy-4nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl] -2H- tetrazolium hydroxide (XTT) cell viability assay kit (Biotium).
Absorbance was measured at 475 and 660 nm using Synergy
HTX Multi-Mode Reader- BioTek Instruments.

2.18 | Tg CRND8 mice injections and
immunohistochemistry
2.18.1

|

Mice

All animal husbandry procedures performed were approved
by the Institutional Animal Care and Use Committee.

TgCRND8 were maintained as described before,51 transgenic
males were crossed with B6C3F1 ntg females.

2.18.2

|

Neonatal injections

TgCRND8 mice were injected with 2 μL of 10 μM isolated oligomers (14LPOs, 16LPOs, LFAOs, and GM1Os) in 10 mM
sodium phosphate buffer at pH 8.00, ICV into both hemispheres using a 10 mL Hamilton syringe with a 30 g needle
on day P0 as described before46,52 and aged till 2 months. Aβ
levels from the Ripa, 2% SDS, and 70% FA-extracted samples were quantified using end-specific sandwich ELISA as
previously described.53 Aβ40 was captured with mAb 13.1.1
(human Aβ35-40 specific; TE Golde) and detected by HRPconjugated mAb 33.1.1 (human Aβ1-16; TE Golde). Aβ42
was captured with mAb 2.1.3 (human Aβ35-42 specific; TE
Golde) and detected by HRP-conjugated mAb 33.1.1 (human
Aβ1-16; TE Golde). ELISA results were analyzed using
SoftMax Pro software.

2.18.3 | Immunohistochemical imaging and
image processing
Right hemibrain was fixed in 4% paraformaldehyde.
Immunohistochemical staining was performed by biotinylated
pan Aβ pan antibody mAb5 (1:1500, T. Golde). To detect we
used biotinylated secondary antibody and ABC-horseradish
peroxidase staining kits (Vector Laboratories, Burlingame,
CA). After development by 3,3′-Diaminobenzidine (DAB)
(Sigma-Aldrich) substrate and counterstaining with hematoxylin, the slides were coverslipped and images were
scanned by Aperio XT System (Leica Biosystems, Buffalo
Gove, IL, USA) and analyzed using either Aperio positive
pixel count or ImageJ program. Brightness and contrast alterations were applied identically on captured images using
Adobe Photoshop CS3.

2.18.4

|

Quantification of Aβ deposition

Aβ plaque burden and intensity of astrogliosis staining were
calculated using the Positive Pixel Count program (Aperio).
At least three sections per sample, 30 μm apart, were averaged by a blinded observer to calculate plaque burden. For
CAA, three blinded observers reviewed the images and
scored the extent of CAA based on the following criteria;
“3” = more than 50% blood vessels have staining along the
full circumference. “2” = 25%-50% of blood vessels have
substantial staining. “1” = some blood vessels are stained
with anti-pan Aβ biotinylated antibody. “0”—no staining observed in blood vessels.
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R E S U LTS

3.1 | Lysophosphatidyl glycerol and GM1
ganglioside micelles promote the formation of
Aβ oligomers
Aβ oligomer formation was investigated in the presence
of LPG micelles containing saturated 14 acyl carbon chain
(C14:0 LPG) or 16 acyl carbon chain (C16:0 LPG) (Figure 1).
Freshly purified Aβ monomer (50 μM) buffered in 20 mM
Tris pH 8.0 and 50 mM NaCl was incubated with C14:0 or
C16:0 LPG micelles and allowed to incubate at 37°C under
quiescent conditions. The final concentration of LPG was
kept at least two-fold above the reported critical micelle
concentration (CMC) to ensure the lipids were in a micellar
form.54 After 48 hours of incubation, aliquots of the reactions
were electrophoresed under partial denaturing conditions and
visualized via immunoblotting, which revealed the presence
of 30-60 kDa oligomers formed in the presence of LPG micelles along with some high molecular weight (HMW) bands
(those that do not enter the gel) and monomers (Figure 1A).
Immunoblot of the control reaction in the absence of LPG
contains only a disperse oligomer band corresponding to
~200 kDa and fibrils that failed to enter the gel, suggesting
that LPGs induce the formation of low molecular weight
(LMW) Aβ oligomers (Figure 1A, lane C). Incubations of
Aβ monomers (50 μM) in the presence of GM1 gangliosides
in similar buffer and temperature conditions show oligomer
bands with a bimodal molecular-weight distribution centered
at ~40 and ~56 kDa, respectively (Figure 1A; GM1). Unlike
LPG incubated reactions, no HMW fibrils were observed in
the immunoblot of GM1-derived oligomers.
Fractionation of LPO incubated samples on a Superdex-75
column (Figure 1B-D) showed three Aβ species corresponding
to monomers, oligomers, and fibrils similar to those observed
in the immunoblots. Fractionation of the control sample in
the absence of LPG or GM1 micelles (Figure 1B-D; dotted
lines) showed only fibrils and monomers, further indicating
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that the oligomers are formed only in the presence of the lipids. Similar fractionation of Aβ incubated with GM1 showed
predominantly two fractions (Figure 1E). Immunoblots of
the fractionated 14LPOs and 16LPOs revealed that the peak
close to the void volume (fraction 17) contained fibrils, as
expected (Figure 1B-C; inset). The fractions eluting in more
inclusive volumes at 18-20 contained the soluble oligomers
(Figure 1B-C; inset), while monomers eluted in fractions
at the most included volume (fraction 25). Similarly, immunoblots of GM1Os (Figure 1D) showed fractions 18-20
containing the oligomers (Figure 1D; inset), and notably,
HMW aggregates in fraction 17 were absent (Figure 1D).
Furthermore, the isolated oligomer samples electrophoresed
under non-denaturing conditions (no heat; no SDS treatment)
showed a differential migration pattern (based on m/z ratio)
for GM1Os compared to other oligomers (Figure S1), which
could suggest either the oligomer is different in size, charge
or both, or the migration pattern is affected by the extent of
lipid association in the oligomers.
Therefore, to investigate whether lipids are associated with
isolated oligomers quantitatively, the samples were analyzed
using electrospray ionization mass spectrometry (ESI-MS) in
negative ion mode (Figure S2). Spectra of the controls, C14:0
LPG, C16:0 LPG, and GM1 in the absence of Aβ showed the
presence of the –1 ion for both C14:0 and C16:0 LPGs at 455
and 483 m/z, respectively (Figure S2A,B). Multiple signals
were observed with GM1 control (Figure S2C) corresponding
to the varying sphingosine (denoted “d”) and acyl moieties
present in the commercial sample. This primarily included
the 1545 ([(d18:1, C18:0) – 1H]-1) and 1573 ([(d20:1, C18:0)
– 1H]-1) m/z ions, which have been observed previously.55-57
Also observed were the 1612 and 1680 m/z ions, which were
unassigned derivatives of GM1, consistent with the presence
of multiple GM1 isoforms based on the manufacturer's note
(Avanti Polar Lipids). Control Aβ reactions either for monomers or LFAOs yielded a 1503 m/z signal corresponding to
the [M − 3H]3− Aβ ion (Figure S2D-E). The [M − 3H]3−
Aβ ion was also observed in the isolated 14LPO and 16LPO

F I G U R E 1 A, SDS-PAGE -immunoblots of the samples of Aβ (50-60 µM in 20 mM Tris, 50 mM NaCl, pH 8.0 and 0.01% NaN3) incubated
with C14:0 (400 µM), C16:0 (150 µM), and GM1 gangliosides (75 µM) lipid micelles above their critical micelle concentrations and imaged
after 48 h of incubation. B-D, Fractionation of samples by SEC of the reactions in (A). The dotted lines are fractionation profiles of the control
reaction in the absence of lipids. (insets; B-D) corresponding SDS-PAGE immunoblots of oligomeric fractions (denoted by the black line). Fraction
numbers are labeled at the bottom of the gels
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F I G U R E 2 A-C, DLS size distribution profiles of oligomers weight by volume fractions from which hydrodynamic diameter (Dh) were
determined. Shown are profiles for nine independent samples of 50-60 µM Aβ in 20 mM Tris, 50 mM NaCl at pH 8.0 and 0.01% NaN3 incubated
with (A) C14:0 LPG (B) C16:0 LPG, and (C) GM1 ganglioside micelles above their respective CMCs in the same buffer for 48 h. D-F, DLS size
distribution profiles for the isolated oligomers after SEC fractionation (six independent samples): (D) 14LPOs. E, 16LPOs and (F) GM1Os. G, Size
distribution based on sedimentation velocity experiments. H, Far UV circular dichroism of 10-16 µM samples of 14LPOs, 16LPOs, LFAOs, and
GM1Os after SEC fractionation. I, FTIR spectra for 14LPOs, 16 LPOs, and GM1Os after SEC isolation along with fibril and LFAO controls.

samples but not the ones corresponding to the free C14:0
LPG (455 m/z) and C16:0 LPG (483 m/z) lipids (Figure S2FG). This suggests that the isolated oligomers have an insignificant amount of lipid association similar to LFAOs as
observed previously.42 In contrast, isolated GM1Os showed
the presence of GM1 gangliosides in the sample, and surprisingly no Aβ signals were observed (Figure S2H), suggesting
that the lipids were associated with the isolated GM1Os. It is
unclear as to why Aβ signals were not observed on the spectrum but it could be due to disruption in ionization caused by
GM1 association. The presence of GM1 in isolated GM1Os
was then quantified by HPLC (Figure S3), which revealed

the presence of ~20% (molar) of GM1 lipid in the isolated
GM1Os (2.5 μM in 12 μM oligomer sample).

3.2 | Biophysical
characterization of oligomers
The size and secondary structure of micelle-derived oligomers, LPO and GM1O samples were analyzed by dynamic
light scattering (DLS), circular dichroism (CD), and Fourier
transform infrared (FTIR) spectroscopies (Figure 2). DLS
size analysis of 14LPO, 16LPO, and GM1O samples before
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SEC isolation revealed some degree of polydispersity with
14LPOs, a significant extent with 16LPOs, and a minimal extent with GM1Os (Figure 2A-C). Both 14LPOs and GM1Os
contained predominant species with ~10 nm diameter and to
a lesser extent large species >0.5 μm. Moreover, 16LPOs
showed three distinct species between 10 nm and 10 μm.
Fractionation of the oligomers by SEC resulted in more
monodisperse isolated fractions centered around 10 nm in diameter (Figure 2D-F). Here too, 16LPOs showed variations
in size between 5 and 10 nm between different preparations
(Figure 2E). Unlike LPOs, both prior to and after SEC isolation, GM1Os displayed monodispersity with DLS spectra
centered at 10 nm (Figure 2C,F), again suggesting that fibril
formation may be minimal in the presence of GM1. This in
turn suggests the possibility that the association of GM1 to
Aβ could lead to a pathway different from fibril formation.
Overall, the data suggest that all three oligomers have largely
similar hydrodynamic diameters that are in the same range
as of LFAOs,42 which is consistent with the SEC and immunoblot data.
More stringent size estimates were performed by
sedimentation velocity experiments. LFAOs showed a
predominant species centered around 5S and a less abundant one around 7S (Figure 2G) corresponding to 60 and
110 kDa (12 and 24mers), respectively, which is consistent with our previous observation.42 The 14LPOs and
16LPOs showed a sedimentation coefficient peak spread
between 5S and 8S (~60-120 kDa) corresponding to 1326mers (Figure 2G). The broad peak suggested heterogeneity especially in the 16LPO sample which the DLS
data also indicates (Figure 2E). GM1Os showed relatively
discrete peaks with a major species centered around 3S,
along with minor ones at 6.5S and 9S that correspond to
9mers, 18mers, and to a lesser extent, 30mers, respectively
(Figure 2G). The secondary structure of the oligomers was
investigated by both far-UV CD and FTIR spectroscopy
(Figure 2H,I). All oligomers showed CD spectra with a
minimum at 217 nm indicative of β-sheet secondary structure (Figure 2H). To ascertain the type of the β-sheets
(parallel or anti-parallel), FTIR spectra spanning the amide-I region was investigated (Figure 2I).58 FTIR spectra
of control fibrils formed in the absence of lipids (dashed
line) and LFAOs (dotted line) showed an absorbance maximum at 1625 cm−1, indicative of parallel β-sheets. Nearly
identical spectra were observed for 14LPOs, 16LPOs,
and GM1Os with a peak at 1620-1625 cm−1 (Figure 2I).
Together with the absence of a peak at 1690 cm−1 indicates a parallel β-sheet structure for the samples. While
these results differ with some reports of Aβ oligomers
containing anti-parallel β-sheets,59-61 they do parallel the
observation for LFAOs,44 which brings to focus a unifying
characteristic among lipid-derived oligomers.
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3.3 | Lipid-derived oligomers have ringlike morphology
Morphological features of the isolated oligomers were investigated by atomic force microscopy (AFM). All the oligomers showed morphology resembling spherical, punctate
dots (Figure 3A,E,I). The 14LPO samples showed largely a
uniform size with height centered at 1.5 nm with a few larger
ones with 3.5 nm (Figure 3C). The 16LPO samples displayed
a mixture of different sizes ranging between 2, 2.5, and 5 nm
(Figure 3G), which is consistent with the heterogeneity observed in DLS (Figure 2E) and sedimentation velocity data
(Figure 2G). GM1Os showed the most homogenous distribution of spherical particles with a height of 2.5-3.0 nm
(Figure 3K), which is also consistent with DLS (Figure 2F).
Sizes of these oligomers are slightly smaller than those observed for LFAOs which were 5-6 nm in height.42,46 The
phase images of the oligomers showed a presence of depression in the middle of the spherical dots, suggesting a ring- or a
doughnut-shape for all the oligomers species (Figure 3B,F,J).
The phase measurements were made as precise topographical
analyses were limited by the large size of the AFM cantilever
tip. The phase analysis describes the energy dissipation and
how the tip interacts with the samples by detecting differences
in the probe's oscillation in reference to the excitation oscillatory signal, while maintaining a constant amplitude. Physical
features that would cause the phase lag to include differences
in surface stiffness, viscoelasticity, adhesion, or topographical variations,62 as we have shown previously.46,63,64 The data
thus derived were further confirmed by the cross-sectional
analysis of the oligomers (Figure 3D,H,L), which is similar
to those observed for LFAOs.46

3.4

|

Stability of Aβ oligomers

Thermodynamic stability of the oligomers was determined
by assessing their ability to resist denaturation by detergent
(1% SDS) as a function of temperature. Upon the addition of
SDS to the oligomers (1 μM), the conformational change from
β-sheet to α-helix was monitored as a function of increasing
temperature (Figure 4A-F). Panels a-e in Figure 4 show farUV CD spectra for pre- and post-melted oligomers and fibrils
at 10 and 90°C, respectively, which show this conformational
transition. The melting profiles were generated by monitoring the transition at λ208 nm, while sweeping the temperature
from 10 to 90°C. Oligomers and fibrils show two-state melting
profiles with a sigmoidal denaturation pattern (Figure 4F). Up
to ~40°C, no changes in the ellipticity was observed for any
of the oligomers (Figure 4F), displaying their ability to resist
denaturation at physiological temperatures. However, some
distinguishable differences were observed in the denaturation
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F I G U R E 3 AFM height and phase images for 1-2 µM samples of freshly isolated oligomers samples imaged on a mica grid: (A-B) 14LPOs,
(E-F) 16LPOs, (I-J) GM1Os. Scale bars represent 50 nm. Statistical height and phase analysis of AFM images for (C-D) 14LPOs, (G-H) 16LPOs,
and (K-L) GM1Os

pattern among oligomers and fibrils. First, all oligomers melted
into different degrees of α-helical structures as determined by
the difference between ellipticities at wavelengths 222 and
208 nm. Although the debate on whether the relative intensity
of ellipticity ([θ]) between λ222 and λ208 indicates the extent of
α-helix or 310 helix seem to be unsettled,65 it is clear that in the
presence of SDS denaturant, helix displays a value of [θ]222
– [θ]208 < 1.0.47-49 This criterion was used in normalizing the
data (see Methods). Based on this analysis, GM1Os displayed
complete melting followed by 14LPOs, while LFAOs and
16LPOs, which showed partial melting but to the same extent
of the helix (Figure 4F). As expected, fibrils resisted melting
to the largest extent with only ~25% of β-sheet melting into
an α-helix (Figure 4F). Differences were also observed for the
mid-point of transition corresponding to the melting temperature (Tm), defined as the temperature at which half of the protein is denatured ([N]/[D] = 0.5). From this analysis, GM1Os
showed the lowest Tm with 60°C followed by 75, 69, and 70°C
for 14LPOs, 16LPOs, and LFAOs, respectively. Further deconvolution of the data showed that the denaturation transition
is largely entropy-driven for GM1Os as compared to others implicating the presence of exposed hydrophobic surfaces on the
oligomers in part by the complexed lipid (Figure S3).
In parallel, the stability of oligomers toward enzymatic
digestion was also probed by proteinase K (PK) treatment.

The oligomers were incubated with (57 ng/mL) of PK and
the stability was assessed based on the disappearance of
the oligomer band from immunoblot as a function of time
(Figure 4G,H). Each oligomer was incubated in small aliquots with PK in the buffer for 10, 20, 30, and 40 minutes
and was subjected to electrophoresis on partially denaturing SDS-PAGE followed by western blotting with monoclonal antibody Ab5. With all oligomers, an immediate
decrease in the band intensity and molecular weight was
observed within 10 minutes of incubation as compared to
the control (C) (Figure 4G). In addition to the reduction in
oligomer band intensity, all oligomers except LFAO control resulted in the generation of fragmented monomers
(Figure 4G; 3.0-4.0 kDa bands). A decrease in the oligomer band intensity was observed with an increase in the
incubation time with PK (Figure 4H). All the oligomers
showed nearly complete digestion within 20 minutes but
GM1Os showed the most susceptibility to PK with complete digestion within 10 minutes (Figure 4H). These results indicate that all the oligomers show somewhat similar
stability toward PK digestion. However, slightly increased
susceptibility for GM1Os may suggest a less compact
structural organization for GM1Os as compared to the
other oligomers which parallel the thermal denaturation
experiment observed (Figure 4F).

SAHA et al.

   

|

11 of 18

F I G U R E 4 A-E, CD spectra of 1 µM
GM1O, 14LPO, 16LPO, LFAO, and fibrils,
respectively, before (black) and after
(grey) their thermal denaturation (10-90°C)
from β-sheet to α-helix in presence of 1%
SDS. F, Normalized denaturation profiles
obtained from CD spectra at 208 nm upon
the addition of 1% SDS and increase in
temperature from 10 to 90°C for: 14LPOs
(●), 16LPOs (○), LFAOs (✰), GM1Os (□)
and fibrils (ᐊ). The spectra were fit with a
Boltzmann's sigmoidal function. G, Partially
denaturing SDS-PAGE -immunoblots of Aβ
oligomers upon digestion with proteinase-K
(PK) enzyme initiated with 1:2500 enzyme:
protein ratio and monitored temporally for
10, 20, 30, and 40 minutes. C is the control
reaction at 0 h without PK. H, Protein band
intensities derived from (G) plotted as a
function of time for GM1Os (□), LFAOs
(✰), 16LPOs (○), and 14 LPOs (●)

3.5 | Conformation-sensitive dyes and
antibodies reveal subtle structural differences
among oligomers relatable to cytotoxicity
The natural product curcumin has been known to bind amyloid aggregates.66-68 Recently, Condello and co-workers
showed that curcumin discriminates between wild-type and
mutant Aβ deposits derived from familial AD and CAA brain
tissue based on the intensity and emission wavelength of the
fluorescence spectrum.66 Similarly, other fluorescent dyes
such as polythiophenes have been shown to display different
fluorescent properties upon binding to the sample tissues from
varying etiological subtypes of AD.17 We evaluated curcumin
fluorescence in the presence of Aβ monomers, oligomers, and
fibrils to explore if any differences in the spectroscopic properties could be discerned (Figure 5). The addition of curcumin
(5 μM) to a solution of monomeric Aβ showed an emission
spectrum centered at 560 nm (■; Figure 5A). All oligomers
such as LFAOs, 14LPOs, 16LPOs, and GM1Os, as well as
control fibrils, showed blue shifts to varying degrees, with

GM1Os showing the maximal shift (Figure 5A,B). In addition,
the oligomers showed variations in the intensity of florescence
upon binding to the dye 8-anilino-1-naphthalenesulfonic acid
(ANS), which is known to bind solvent-exposed hydrophobic
surfaces (Figure 5C). LFAOs, 14LPOs, and 16LPOs showed
identical increases in the intensity, while GM1Os showed
nearly double the intensity compared to the rest of the oligomers (Figure 5C). We rule out that the increase is due to the lipid
associated with GM1Os as compared to the blank lipid sample
(data not shown). However, the contributions of lipid-induced
structural changes leading to the exposure of hydrophobic surfaces cannot be ruled out. 1D 1H NMR spectra of the amide region for the oligomers indicated significant differences in the
spectra of GM1Os as compared to the others with many amide
resonances shifted or unobserved (Figure 5D), suggesting different dynamics of conformational exchange and structure for
the oligomers. Immunodetection by conformation-specific
antibodies, A11 (oligomer-specific) and OC (fibril-specific)
indicate that LFAOs, as previously known, and 14LPOs show
OC-positivity (Figure 5E). While 16LPOs and GM1Os also
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F I G U R E 5 A, Normalized fluorescence emission scans for curcumin (5 μM in 25% EtOH) binding to 5-10 uM Aβ monomers (■), LFAOs
(✰), 14LPOs (●), 16LPOs (○), GM1Os (▼), or fibrils (◁). B, Shifts in the emission maximum from that of the monomers (ΔλEmmax ) of the
samples in (A). C, Blank corrected intensities of λEmmax for ANS dye (100 μM in 20 mM Tris pH 8.0) binding to 3 μM oligomers. D, 1D 1H NMR
spectra of the amide region for the oligomers that show backbone structural differences and similarities between the oligomers. E, Dot blots for
the oligomers and monomers using sequence-specific Ab5 monoclonal antibody and conformation-specific monoclonal antibodies A11 (oligomerspecific) and OC (fibril-specific). F, Viability for SHSY5Y neuroblastoma cells measured by XTT assay upon incubating with oligomers expressed
in terms of % of dead cells. n = 3 independent cell cultures on isolated oligomers; *, ** and *** P < .05 based on one-way ANOVA analysis

show OC-positive detection, they also showed a somewhat diminished A11-positive character (Figure 5E). To see whether
the differences observed for GM1Os manifest in their cellular
toxicities, the viability of SHSY5Y neuroblastoma cells upon
treatment with the oligomers were investigated by XTT assay.
After 40 hours of treatment, nearly 60% of the cells died due
to GM1O exposure, while only ~40% were dead upon exposure with other oligomers (Figure 5F). Together, the data suggest that the biophysical differences between the oligomers
correlate with their respective cellular toxicities.

3.6 | Lipid-derived Aβ oligomers
show differential seeding resulting in
morphologically different fibrils
Structural differences among oligomers often manifest in the
morphology of their seeded fibrils. To see if the oligomers
show differences in fibril morphologies generated upon seeding monomers, reactions were initiated by seeding Aβ monomer (25 μM) with 5 μM (20%) of 14LPOs (◊), 16LPOs (▽)
or GM1Os (○) seeds individually. Reactions were buffered
in 20 mM Tris (pH 8.0) with 50 mM NaCl and were maintained under quiescent conditions at 37°C. The aggregation
reactions were deliberately initiated with high seed amounts
(20%) and under quiescent conditions to minimize nucleated

aggregation reaction among monomers and to maximize templated, seeded aggregation by the oligomers. The samples
were centrifuged after 30 days of incubation at 37°C, and the
sedimented pellets were washed with buffer and subjected to
analysis by AFM. Samples for 14LPOs, 16LPOs, and GM1Os
showed fairly smooth fibrils on the mica grid (Figure 6A,D,G,
respectively). Detailed analysis of the morphologies, however, revealed that both 14LPO-seeded and 16LPO-seeded
fibrils displayed periodic repeats of crests and troughs along
the length of the fibril (Figure 6A,D; white arrows) with 3.04.5 nm heights (Figure 6B,E; right panels). These heights
are identical to those observed for individual oligomers
(Figure 3), leading us to conjecture that the fibrils were comprised of individual oligomer units that give rise to “repeat
morphology.” Identical morphology was observed previously
for LFAO-seeded fibrils.9 The cross-sectional analysis perpendicular to the fibril axis (colored lines) showed heights of
~4.0 and 6.0 nm for 14LPO-seeded and 16LPO-seeded fibrils,
respectively (Figure 6D,G; right panels). This was consistent
in many different fields in the mica grid (Figure 6J). In sharp
contrast, GM1O-seeded fibrils did not show such a repeat
morphology but showed a cross-sectional height of ~5 nm
(Figure 6G,H,I,I). Together, these results indicate that both
14LPOs and 16LPOs are able to generate fibrils of similar
morphologies, GM1Os showed significant deviations both in
temporal profiles and fibril morphology.
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F I G U R E 6 A, D, G, AFM images of Aβ fibrils generated from
obtained from aggregation kinetics of Aβ monomers (25 μM) seeded
with 5 μM of 14LPOs, 16LPOs or GM1Os in 20 mM Tris, pH 8.0,
with 50 mM NaCl and 50 μM ThT at 37°C under quiescent conditions
after 30 days of incubation. Scale bar is 200 nm. Statistical height
analysis along cross-sectional and longitudinal axes on the AFM
images indicated by colored lines and arrows, respectively, for; (BC) 14LPO-seeded, (E-F) 16LPO-seeded, and (H-I) GM1O-seeded
fibrils. J, Cross-sectional height analysis of the fibrils visualized on at
least twelve different fields from at least three independent data sets.
The data obtained from these also show no “repeat morphology” for
GM1Os, unlike other two oligomers

3.7 | Aβ oligomers injection into Tg CRND8
mice induce amyloid pathology and vascular
amyloid deposition
Based on the aforementioned biophysical data and the previously observed effects of LFAOs on amyloid accumulation
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and CAA formation in CRND8 mice,9 we set to test whether
the introduction of the oligomers to the neonatal brains of
AD transgenic mice will result in the extended propagation
of oligomers and fibril deposition. Thus, 4 μL of 10 μM
preparations of 14LPOs, 16LPOs, and GM1Os along with
Aβ42 monomers and LFAOs as controls were bilaterally
injected into the cerebral ventricles of three litters of newborn Tg CRND8 mice. After three months, the mice were
euthanized and brains were extracted. One hemibrain was
frozen for further biochemical analysis, while the other
was fixed in 4% paraformaldehyde, paraffin-embedded,
and processed for immunostaining. Upon analysis, the control mice injected with Aβ42 monomer exhibited a sparse
number of small amyloid deposits both in the cortex and
hippocampus, whereas the injection of LFAO resulted in
increased levels of Aβ40 and Aβ42 in both SDS and formic acid (FA) fractions similarly to what was shown in
(Figure 7A-F).9 LFAO administration also expedited the
accumulation of amyloid in the CAA as previously observed (Figure 7G,I).9 Interestingly, injection of 14LPOs
did not alter Aβ levels in the SDS fraction significantly but
did so in the FA-soluble fractions, suggesting that the oligomers induced insoluble fibrils deposition. It also did not
affect the accumulation of CAA in the vasculature. In contrast, 16LPO injection resulted in increased levels of Aβ42
in SDS-soluble fraction as well as increased Aβ40 and
Aβ42 in FA-soluble fraction. The oligomers also induced
an increased burden of CAA-laden vessels (Figure 7G,I).
GM1O administration to neonatal CRND8 mice also resulted in increased Aβ levels in both SDS and FA fractions,
similar to LFAOs and 16LPOs (Figure 7C-F). Overall, we
demonstrate a twofold increase in Aβ40 and Aβ42 in SDSsoluble and SDS-insoluble FA-soluble fractions of GM1Os
compared to the monomer control. Furthermore, GM1Os
induced widespread CAA in cerebral vasculature and overall Aβ burden (Figure 7G-I). However, injection of all the
oligomers samples at lower concentrations (1 μM) did not
result in significant amyloid accumulation in the brains
(Figure S5). Together, these suggest that LFAOs, 16LPOs,
and GM1Os propagate and induce amyloid deposition in
parenchyma and cerebral vasculature with GM1Os and
16LPOs showing the maximal effect.

4

|

DISCUSSION

Monomeric Aβ peptides self-associate to form large fibrillar aggregates that deposit as insoluble, protease-resistant
plaques in AD. NMR structures of fibrils propagated in vitro
using brain-derived amyloid seeds as templates have revealed
structural differences between morphologically distinguishable aggregates.15,69 Similarly, conformation sensitive fluorescent dyes have also identified the presence of heterogeneous
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F I G U R E 7 Oligomers induce widespread amyloid deposition and CAA in TgCRND8 mice. Newborn CRND8 mice were injected with
4 μL aliquots of Aβ42 monomers, LFAOs, 14LPOs, 16LPOs, and GM1Os (10 μM) in the cerebral ventricles. Three months later, brains were
extracted and one hemibrain was frozen, while another was fixed and stained with anti-pan- Aβ mAb5 Biotin antibody. A-F, Biochemical analyses
of sequentially extracted Aβ42 and Aβ40 levels by end-specific sandwich ELISA show significantly increased SDS soluble and FA soluble
Aβ levels in LFAOs, 16LPOs, and GM1Os injected mice compared to monomer injected mice. Data represent mean ± sem. n = 6-10 mice
per group. N = 6-10, *P < .05, **P < .01, ***P < .001, ****P < .0001, one-way ANOVA). G, Amyloid staining of plaques and CAA in the
representative paraffin sections is shown in the cortex and meningeal vessels of injected mice. Scale Bar, 500 μm (cortex), 100 μm (hippocampus).
H, Quantification of Aβ positive immunostaining shows significantly increased amyloid plaque burden (immunostained with anti-pan-Aβ
mAb5Biotin). Data represent mean ± SEM. n = 6-10/group. **P < .01, ***P < .001, one-way ANOVA. I, Quantification of CAA. Aβ positive
blood vessels in the meninges and throughout the brain tissue were evaluated in a blind manner and given a qualitative score from 0 to 3. Vessels
with scores 0, 1, 2 or 3 were counted. Data represent mean ± sem. n = 6-10 per group. ***P < .001, one-way ANOVA

aggregate conformations in the brain that correlate with diverse phenotypes in AD such as those corresponding to late
or early onset, rapidly progressing or anatomical region of
deposition.17,66 Top-down discoveries such as these have unequivocally established that differences in aggregate structures may lead to different phenotypes in the brain. Since
low molecular weight soluble oligomers are known to be the
primary toxic species in the aggregation pathway, a question
then arises as to whether conformationally distinct oligomers are capable of faithful propagation of their structures toward distinguishable fibril morphologies, and if so, whether
such a propagation will manifest in phenotypic differences in
the AD brains. Here, we approached to answer this question
bottom-up by generating distinct oligomer sub-types and correlating their biophysical properties with observable effects
in transgenic AD mice brains. We have earlier demonstrated
that LFAOs generated in the presence of fatty acid propagate their structure toward distinct fibrils on the mesoscopic
scale and selectively induce CAA in a transgenic AD mouse
model.9 Here, we used micelle forming phospholipids and a
sphingolipid to generate stable oligomers, characterize their
biophysical differences and similarities, and correlate them
with the phenotypes induce in C8ND8 mice.
The results obtained here bring forth several salient inferences. First, the micellar anionic phospholipids promote the
formation of disperse ~60-120 kDa (5-8S) Aβ42 oligomers,

which corresponds to a 12-26mer species. Despite being
somewhat heterogenous, this size is comparable to the earlier characterized LFAOs,42 which suggests that the carbon
chain length variations (12, 14, or 16 carbon acyl chains) do
not seem to have a noticeable effect on the size of the oligomer generated. However, LFAOs were generated with fatty
acid near its CMC and not above, which implicates the significance of micelles in the case of phospholipids. Second,
micelles of the neutral sphingolipid GM1 ganglioside induce
the formation of slightly smaller and more discrete ~40 and
80 kDa (3 and 6.5 S) species corresponding to 9 and 18mers.
The slightly different sizes obtained from GM1 lipids could
be attributed to neutral charge, longer acyl chains (18,20),
carbohydrate moiety, or all three.
Among the isolated oligomers reported here, GM1Os
stand out as a distinct outlier on the observed biophysical and
biochemical attributes. GM1Os do share similarities on parallel β-sheet secondary structure and a ring-like morphology
as well as the size range. However, they show stark biophysical differences too (Figure 8). For example, the amide region
of the 1H NMR spectra indicates structural dynamics and
assembly differences in GM1Os which is corroborated by
the greater degree of exposed hydrophobic surfaces by ANS
binding and decreased enzymatic and thermal stabilities.
Similarly, GM1Os and 16LPOs show reactivity toward both
conformation-specific A11 and OC antibodies unlike the
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other two which show only OC specificity. Such differences
are also manifested in their ability to propagate morphologically distinct fibrils; 14LPOs and 16LPOs but not GM1Os,
generate fibrils containing a “repeat” morphological feature
similar to LFAOs.9 These observations are summarized in
Figure 8 that show biophysical differences among the oligomers investigated in this study. Such biophysical differences
also have direct and correlatable manifestations in vivo. Cell
viability assays indicate that GM1Os to be the most potent in cellular toxicity as compared to the other oligomers.
Similarly, in CRND8 mice too, GM1Os showed profound
effects on both the induction of total Aβ burden and CAA.
Surprisingly, despite significant biophysical differences,
GM1Os, 16LPOs, and LFAOs show high but comparable effects on amyloid deposition in CRND8 mice.
There can be several features within the lipid that are attributable to the generation of Aβ oligomers and their observed
properties. It is possible that the development of pathology
following Aβ seeding depends tightly on the size and solubility of initial seeds and not on their biochemical properties.70
The oligomers compared here have somewhat similar sizes;
however, the lipid characteristics are different; in comparison
to the anionic LPGs used in this study, GM1 gangliosides differ in acyl chain lengths, charge, and head groups, which may
confer GM1Os their distinctive properties. A recent report on
the interactions of Aβ with synthetic glycopolymer mimics
revealed the selective induction of Aβ oligomers by glycopolymers containing purely glucose pendant groups,71 which
implicates that sugar distribution in GM1 ganglioside is important for oligomer generation. In addition, ~20% of isolated
GM1Os contain GM1 lipid which could also have a role to
play in their behavior in mice. The increased hydrophobic
character is consistent with the lipid-bound oligomer form,
which may manifest in its lipid solubility, bioavailability, and
seeding in vivo. It is also rational to conjecture that a stable
oligomer strain is more likely to be present in a lipid-bound
form than in a purely homogenous form. Such a contention is
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also consistent with earlier reports on Aβ oligomers isolated
from postmortem AD brains that were associated with GM1
gangliosides.28,29 GM1 gangliosides are important components of lipid rafts that have been known to play important
roles in AD.30 Therefore, it is comprehensible that lipid association to the isolated GM1Os could play a role in their biophysical and biochemical distinctions. The slightly decreased
PK stability of GM1Os seems to be counter-intuitive to their
effect on mice brains. It is possible that the lipid association
is partly responsible for the exposure of polypeptide backbone for increased enzymatic cleavage, but the lipid association could also increase the lipophilicity of the oligomers to
effectively propagate in parenchyma, meninges, and cerebrospinal fluid.
The results presented here demonstrate that oligomers
with distinct properties can be tuned by changing the physiochemical properties of lipids and support the hypothesis
that varying lipid environments could play important roles in
the generation of conformeric oligomer strains.72 Along the
same lines, these also lead to the conjecture that while oligomers may have different structures to present themselves as
conformational “strains,” they may also possess common
features and traits such as those observed for oligomers derived from anionic lipids. Despite the numerous challenges
these oligomers present, understanding the atomic details of
their structures would be essential to further decipher their
mechanisms and functions. Furthermore, understanding the
physiological relevance of lipid-derived oligomers by investigating their in vivo behavior in detail would be essential. In
addition, the ability of these oligomers to propagate cell-tocell transmissions needs to be assessed to assess their propensity to truly behave like infectious prions or “strains”.73-76
Although the in vitro oligomers presented here clearly show
pathology in mice, ascertaining whether and how they represent those present in human brains is important. Recent
reports on the structure of in vitro fibrils generated by the
propagation of brain-derived seeds have made a significant

F I G U R E 8 Summary of results indicating the differences and similarities between the oligomers. The grey boxes indicate the salient
differences in GM1Os as compared to the others; “=” and “≠”, respectively, indicate similar or dissimilar to other oligomers
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leap in this regard. However, it is non-trivial to investigate
oligomers derived from brain samples due to their transiency,
heterogeneity, and difficulty to isolate. Despite these issues,
characterizing them continues to remain as a major focus in
ours and other laboratories. Nevertheless, the data presented
here as such showcase the generation of biophysically distinct oligomers by modulating the lipid characteristics, and
one that correlates to their biochemical proprieties in vivo.
Establishing such structure-phenotype correlations are imperative to decipher the mechanisms by which oligomers impart strain-like properties.
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